tree taxa. An important additional concern is that very few nonviolent suicides were recorded in ragweed season, and since the classification comes from vital statistics data, misclassification could have a large impact on our findings for cells with few events.
Several key factors necessarily remain unmeasured in our data, such as allergen and light exposure, and medical and psychiatric history. While our result may have been confounded by a number of biological and psychosocial factors (such as impact of feeling sick), acting during the allergy season on individuals and their social support systems, the drug treatments of allergies are particularly relevant. Specifically, overthe-counter medications containing pseudoephedrine may worsen prosuicidal factors such as insomnia, agitation, anxiety, and impulsivity, and antihistamines may cause somnolence and cognitive disturbance. Systemic corticosteroids used for more severe symptoms can precipitate depressive, mixed, or manic episodes. Other confounding seasonal factors that peak during late winter and early spring, such as certain viral infections (corona viruses, influenza), 8 may induce inflammation and increased cytokine production in early spring. Alternatively, late winter and early spring decrements in immune defenses 8 against neurotropic pathogens 9 could also result in seasonal decompensation of mood disorders.
Nevertheless, the link between the activation of the immune system with depression and possibly suicide may be directly related to the increased expression of cytokines during immune activation. Several mechanisms that may explain this association are currently under investigation. Further studies are necessary to define environmental factors, which, in interaction with genetic and developmental vulnerability and resilience, may contribute to the seasonal peaks of suicide. This research may contribute to the stressdiathesis concept of depression-induced suicide, 10 open new perspectives regarding the environmental precipitants of suicidal behavior, and lead to the development of novel therapeutic approaches to prevent suicide.
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We have previously reported that linkage analysis of BP with psychosis (psychotic BP) suggests novel susceptibility loci for BP, and that some of the linkage signals are also implicated in schizophrenia. 1 Here we hypothesize that nonpsychotic BP might produce linkage findings that differ from those reported for psychotic BP.
We have reanalyzed our previous genomewide scan data 2 using nonpsychotic BP as the disease phenotype. Our clinical sample, genotyping protocol, and linkage analysis methods have been published. 2 Briefly, the genotyped sample includes 373 individuals in 40 pedigrees with high density of BP. Bestestimate consensus diagnoses are based on the Research Diagnostic Criteria (RDC) 3 using all available sources of information. Three diagnostic models are used: BP1 (BPI disorder), BP2 (BPI plus BPII disorders), and BP3 (same as BP2 plus recurrent major depression, or MDD). These models are the same as those employed in our initial genome scan analysis, 2 except that psychotic individuals are not considered affected. The three models include 51, 137, and 228 nonpsychotic affected individuals, respectively, with the following distribution of diagnoses: BPI, 51; BPII, 86; and recurrent MDD, 91. The 'unknown' phenotypes consist of disorders that are not coded as 'affected' under a particular model (including psychotic individuals). Our genotyping procedure is fluorescence-based, with PCR products separated and detected on ABI 377 DNA sequencers, and with allele sizes called automatically using GENOTYPER v. 2. 4 We have employed 343 microsatellite markers, with average marker spacing of 10 cM and average heterozygosity and polymorphic information contents of 0.75 and 0.72, respectively. The MLINK program from the FASTLINK package 5 is used for parametric linkage analysis, with the parameters described in our initial genome scan paper.
2 Unaffected individuals are coded as unknown, to reduce the impact of nonpenetrant disease alleles on the analysis. Table 1 shows two-point linkage results that meet Lander and Kruglyak's 6 criteria for genome-wide suggestive linkage (lod score X1.9). Also shown are 'near-suggestive' lod scores (41.5 but o1.9) and multipoint lod score (MLOD) results. Two loci show evidence of suggestive linkage: D3S1285 at 3p14.1 and D8S1100 at 8q24.2. Three other loci show more moderate lod scores: D1S1612 at 1p35.3, D3S2460 at 3q13.3, and D6S1003 at 6q24.2. The MLOD results are generally consistent with the two-point lod scores, though multipoint parametric analysis of complex traits may result in deflated lod scores. 7 Consistent with our hypothesis, these loci show no clear evidence of linkage in our previous analysis of psychotic BP. 1 Possible exceptions are D8S1179 on 8q and D6S474 on 6q, 1 though these loci are 20 and 26 cM away, respectively, from the loci implicated in this study. Also, our initial genome scan, 2 where no distinction is made between psychotic and nonpsychotic BP, shows no appreciable linkage to any of the 'non-psychosis' loci in the current analysis. A metaanalysis of all published genome scans, which likewise have not separated nonpsychotic BP from BP as a whole, 8 shows marginal evidence of linkage to 8q24.2-qter, though this region has wide boundaries (30 cM). Other studies (reviewed in Dick et al Our results suggest that (1) some psychotic and nonpsychotic varieties of BP may be governed by different susceptibility loci, and (2) lumping of psychotic and nonpsychotic BP may weaken some linkage signals that are more readily detectable when the two phenotypic subtypes are analyzed separately. Further study is needed to confirm these findings and to search for other loci that may follow a similar pattern. including a locus on chromosome 15q. [2] [3] [4] The Dyslexia Susceptibility 1 Candidate 1 gene (DYX1C1, EKN1, Locus ID: 161582) was recently cloned from the 15q breakpoint of a translocation that cosegregates with DD in a single family. 5, 6 Two plausibly functional SNPs in the gene were subsequently shown to be associated with DD (À3G4A; P ¼ 0.002, 1249G4T; P ¼ 0.006; cases n ¼ 106; controls n ¼ 194), 6 suggesting that DYX1C1 might be involved in susceptibility to DD in the general population. The data we present in this report, based on a DD sample showing association with 15q, do not support this hypothesis.
We genotyped the markers in a sample of 247 Caucasian, UK parent-proband trios (mean age ¼ 13.24 years, age range ¼ 7.92-17.17 years, IQ 485, reading ability 42.5 years behind chronological age). Full phenotypic measures are described elsewhere. 4 SNPs were genotyped using Amplifluor. 7 In keeping with another replication study, 8 neither marker was associated with categorical DD (Table 1) . We also found no evidence for association with marker rs11629841 (located in intron 4 of DYX1C1), which was associated with categorical DD in the latter study 8 (P ¼ 0.018; n ¼ 83 families; 83 DD probands and 18 DD siblings).
In addition to the single marker finding, the study of Wigg and et al 8 reported association between categorical DD and haplotypes containing rs11629841 and either rs3743204 (P ¼ 0.055) or rs692691 (P ¼ 0.013). These extra SNPs were not genotyped in our sample because the overtransmitted rs3743204C/rs11629841G haplotype 8 is fully defined by the rs11629841G allele, while the rs3743204/ rs11629841 haplotype association reflects overtransmission of both haplotypes carrying the G allele of rs11629841 and undertransmission of both haplotypes carrying the T allele (details generously provided by the authors). Our data are incompatible with those findings since in our sample, the G allele is undertransmitted (Table 1) .
In both previous studies, 6,8 a haplotype constructed from À3G4A and 1249G4T yielded modest evidence for association. However, in the former, the associated haplotype was À3A/1249T, in the latter, it was À3G/ 1249G. In our own sample, we found no evidence for association with either haplotype (respectively, P ¼ 0.37 and 0.41, 1 df tests) (Supplementary Table 1 . Available at http://www.uwcm.ac.uk/psychological_medicine/ pub_data/ekn1.htm). The discrepancies between the three studies in the patterns of association strongly suggest that these SNPs are not themselves directly associated with DD, notwithstanding that À3G4A disrupts three predicted transcription factor binding sites and 1249G4T encodes a truncated protein.
In the second study, 8 À3G was additionally associated with certain subcomponents of dyslexia defined quantitatively in a sample of 148 families containing 202 children. Again, we were unable to replicate any of those findings using quantitative measures (Supplementary Tables 2-6 ).
Since association between DD and chromosome 15q (D15S994) had been shown before in our sample, 4 we undertook LD analysis between the three SNPs in 
